| DC Field | Value | Language |
|---|
| dc.contributor.author | Kolesnichenko, P. D. | - |
| dc.contributor.author | Shcheblykin, D. V. | - |
| dc.contributor.author | Demidenko, A. N. | - |
| dc.contributor.author | Reznikov, K. M. | - |
| dc.contributor.author | Alhamzah Muhi Aldeen Azeez | - |
| dc.contributor.author | Zhuchenko, M. A. | - |
| dc.contributor.author | Demchenko, S. A. | - |
| dc.date.accessioned | 2020-06-09T10:43:46Z | - |
| dc.date.available | 2020-06-09T10:43:46Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.citation | The cardio- and endothelial protective effects of ethyl methyl hydroxyl pyridine malate in modeling L-name induced nitric oxide deficiency / P.D. Kolesnichenko, D.V. Shcheblykin, A.N. Demidenko [et al.] // Journal of international pharmaceutical research. - 2019. - Vol.46, №4.-P. 267-271. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/31691 | - |
| dc.description.abstract | Currently, endothelial dysfunction is considered as a predictor of a number of pathologies, including arterial hypertension, ischemic heart disease, chronic heart failure, and is also a pathogenetic component of organ damage in diabetes, hypo estrogenic and other conditions. The purpose of the study is an experimental study of the cardio and vasoprotective effects of etoxidol under conditions of endothelial dysfunction | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | ethyl methyl hydroxyl pyridine malate | ru |
| dc.subject | L-name | ru |
| dc.subject | endothelial dysfunction | ru |
| dc.subject | cardio protection | ru |
| dc.title | The cardio- and endothelial protective effects of ethyl methyl hydroxyl pyridine malate in modeling L-name induced nitric oxide deficiency | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
